MC1R and breast cancer: To eliminate the effects of other oncogenic pathways in breast cancer cells and to confirm the mechanisms contributing to MC1R-driven cell proliferation, we used HEK 293 T cells transiently overexpressing MC1R (Supplementary Fig. 6a, b).